West Pharmaceutical Services, Inc.WSTNYSE
Loading
Asset Growth TrendStable
Percentile Rank64
3Y CAGR-23.8%
5Y CAGR-13.3%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-23.8%/yr
vs +50.6%/yr prior
5Y CAGR
-13.3%/yr
Recent deceleration
Acceleration
-74.4pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 4.00% |
| Q3 2025 | 3.87% |
| Q2 2025 | 9.25% |
| Q1 2025 | -0.69% |
| Q4 2024 | -0.86% |
| Q3 2024 | 5.32% |
| Q2 2024 | -3.13% |
| Q1 2024 | -5.93% |
| Q4 2023 | 1.99% |
| Q3 2023 | 2.32% |
| Q2 2023 | -1.45% |
| Q1 2023 | 2.95% |
| Q4 2022 | 9.04% |
| Q3 2022 | -1.34% |
| Q2 2022 | 2.03% |
| Q1 2022 | -0.58% |
| Q4 2021 | 5.45% |
| Q3 2021 | 7.13% |
| Q2 2021 | 7.07% |
| Q1 2021 | -1.94% |
| Q4 2020 | 8.17% |
| Q3 2020 | 7.96% |
| Q2 2020 | 6.49% |
| Q1 2020 | -4.05% |
| Q4 2019 | 7.70% |
| Q3 2019 | 2.39% |
| Q2 2019 | 4.27% |
| Q1 2019 | 27.87% |
| Q4 2018 | -18.17% |
| Q3 2018 | 3.86% |
| Q2 2018 | 0.22% |
| Q1 2018 | 0.37% |
| Q4 2017 | -3.50% |
| Q3 2017 | 4.74% |
| Q2 2017 | 6.32% |
| Q1 2017 | 0.98% |
| Q4 2016 | -1.07% |
| Q3 2016 | 1.77% |
| Q2 2016 | 2.21% |
| Q1 2016 | -1.59% |